A patent estate invented by Drs. Xiaoyuan Chen and Orit Jacobson and assigned to Molecular Targeting Technologies (MTTI) covers a radiotherapeutic with prospective applicability for treating Neuroendocrine Neoplasms. They are abnormal and excessive growth of tissue...